Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
VRN Stock Forecast 2026-2027
$6.01
Current Price
$3.69B
Market Cap
Buy 5
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to VRN Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
VRN Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+0.5%
1 Year Change
0.0%
Year-to-Date Change
-34.2%
From 52W High of $9.14
+36.9%
From 52W Low of $4.39
📊 TOP ANALYST CALLS
Did VRN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Veren is one of their latest high-conviction picks.
Latest VRN Stock Price Targets & Analyst Predictions
VRN has shown a year-to-date change of 0.0% and a 1-year change of 0.5%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for VRN. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VRN Analyst Ratings
5
Buy
0
Hold
0
Sell
VRN Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $6.01
Latest VRN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VRN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 1, 2024 | RBC Capital | Michael Harvey | Outperform | Maintains | $10.00 |
| Oct 18, 2024 | Raymond James | Luke Davis | Strong Buy | Initiates | $13.00 |
| Jul 12, 2024 | Scotiabank | Sector Outperform | Maintains | $15.00 |
Veren Inc. (VRN) Competitors
The following stocks are similar to Veren based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Veren Inc. (VRN) Financial Data
Veren Inc. has a market capitalization of $3.69B with a P/E ratio of 18.2x. The company generates $2.91B in trailing twelve-month revenue with a 6.9% profit margin.
Revenue growth is +5.6% quarter-over-quarter, while maintaining an operating margin of +15.1% and return on equity of +4.2%.
Valuation Metrics
Market Cap
$3.69B
Enterprise Value
$4.93B
P/E Ratio
18.2x
PEG Ratio
7.9x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
+5.6%
Gross Margin
+55.0%
Operating Margin
+15.1%
Net Margin
+6.9%
EPS Growth
+12.2%
Financial Health
Cash/Price Ratio
+0.5%
Current Ratio
0.6x
Debt/Equity
45.3x
ROE
+4.2%
ROA
+3.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Veren Inc. (VRN) Business Model
About Veren Inc.
What They Do
Develops innovative therapies for unmet medical needs.
Business Model
Veren Inc. generates revenue through the discovery and development of biotechnology solutions, focusing on therapies for rare and complex diseases. The company partners with academic institutions and pharmaceutical firms to enhance its research capabilities and expedite the drug development process, which can lead to licensing agreements and commercialization once therapies are approved.
Additional Information
Veren Inc. is located in a major biotech hub, positioning itself strategically within the industry. Its strong pipeline of drug candidates and commitment to advanced research contribute to its influence in the biotechnology sector, attracting investor interest in healthcare innovations.
Company Information
Sector
Energy
Industry
Oil & Gas E&P
Employees
746
CEO
Mr. Craig Bryksa
Country
Canada
IPO Year
2003
Website
www.vrn.comVeren Inc. (VRN) Latest News & Analysis
Latest News
WHITECAP RESOURCES INC. AND VEREN INC.
11 months ago
Quick Summary
Whitecap Resources Inc. will acquire Veren Inc. in a business combination approved by the Court of King's Bench of Alberta. Veren shareholders will receive 1.05 Whitecap shares per Veren share.
Why It Matters
The acquisition of Veren by Whitecap could enhance Whitecap's market position and growth potential, impacting stock valuations and investor sentiment in the energy sector.
Source: PRNewsWire
Market Sentiment:
Neutral
Wall Street Analysts Think Veren (VRN) Could Surge 34.97%: Read This Before Placing a Bet
11 months ago
Quick Summary
Wall Street analysts' average price target for Veren (VRN) suggests a potential upside of 35%, supported by a positive trend in earnings estimate revisions.
Why It Matters
The 35% upside in price targets suggests strong potential for Veren (VRN) growth, while positive earnings revisions could further enhance investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Veren (VRN) is anticipated to outperform earnings expectations in its upcoming report, based on strong indicators. Investors should prepare for the release.
Why It Matters
Veren's potential for an earnings beat may boost investor confidence, positively impacting stock performance and attracting more interest in the company.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
An investor sold oil stocks to buy a large position in Whitecap Resources, citing strong Q1 results, a beneficial merger with Veren, and a sustainable 9% dividend yield.
Why It Matters
Whitecap Resources' strong Q1 performance and promising merger synergies enhance its financial stability, ensuring a sustainable dividend yield, which could attract investors seeking reliable returns.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Three dividend stocks to consider for 2025 are SLB, IMO, and VRN.
Why It Matters
The mention of SLB, IMO, and VRN indicates potential opportunities for steady income through dividends, which can attract income-focused investors and impact stock demand.
Source: Zacks Investment Research
Market Sentiment:
Positive
Wall Street Analysts See a 27.59% Upside in Veren (VRN): Can the Stock Really Move This High?
1 year ago
Quick Summary
Wall Street analysts have set a price target for Veren (VRN) indicating a potential 27.6% upside, supported by positive earnings estimate revisions.
Why It Matters
The 27.6% potential upside suggests significant growth potential for Veren (VRN), while positive earnings estimate revisions may boost investor confidence and drive stock prices higher.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About VRN Stock
What is Veren Inc.'s (VRN) stock forecast for 2026?
Analyst forecasts for Veren Inc. (VRN) are not currently available. The stock is trading at $6.01.
Is VRN stock a good investment in 2026?
According to current analyst ratings, VRN has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VRN stock?
Price predictions from Wall Street analysts for VRN are not currently available. The stock is trading at $6.01.
What is Veren Inc.'s business model?
Veren Inc. generates revenue through the discovery and development of biotechnology solutions, focusing on therapies for rare and complex diseases. The company partners with academic institutions and pharmaceutical firms to enhance its research capabilities and expedite the drug development process, which can lead to licensing agreements and commercialization once therapies are approved.
What is the highest forecasted price for VRN Veren Inc.?
Price targets from Wall Street analysts for VRN are not currently available. The stock is trading at $6.01.
What is the lowest forecasted price for VRN Veren Inc.?
Price targets from Wall Street analysts for VRN are not currently available. The stock is trading at $6.01.
What is the overall VRN consensus from analysts for Veren Inc.?
The overall analyst consensus for VRN is bullish. Out of 3 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are VRN stock price projections?
Stock price projections, including those for Veren Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 9:24 PM UTC